Please assess the completion status of the following clinical trial:

Trial Title: Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal Cancer

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* newly diagnosed cases histologically as squamous cell carcinoma,~* a performance status 0 to 2,~* white blood cells \>3,000/microL,~* platelets \>100,000/microL,~* serum total bilirubin \<2.0 mg/dl,~* serum transaminase \<3 times the upper normal limit,~* serum creatinine \<1.5 mg/dl,~* creatinine clearance \>60 ml/min~Exclusion Criteria:~* serious cardiac disease~* prior chemotherapy and radiotherapy

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Chemoradiotherapy

Based on this trial design, predict the completion outcome and termination type (if applicable).